October 30, 2012 · 8:54 pm
We just posted a report on the XIMA Trial which studied stents in octogenarians. The trial compared drug-eluting with bare-metal stents and the results are very interesting: while the trial didn’t find a difference in these two types of stents for the pre-specified composite endpoint of death, heart attack, revascularization, stroke and major bleeding…it did find significantly lower incidence of revascularization and heart attack in those patients who received the drug-eluting Xience stent.
But the real take-away from the XIMA Trial is that stenting and angioplasty in the elderly is safe and effective. Mortality from cardiac causes in this trial was 4% at one year, no matter which stent was used. Continue reading →
October 17, 2012 · 11:57 pm
Today’s report from the ACC CathPCI Registry data has some interesting statistics, among them a significant increase in the transradial approach, in which balloons and stents are directed to the heart via the radial artery in the wrist. As I’ve discussed for several years now, the radial approach is utilized much more outside of the U.S. — but it is catching on here…finally.
Dr. Sunil V. Rao
Four years ago we wrote about a study, authored by Dr. Sunil V. Rao, that also used data from the CathPCI registry for the years 2004-2007. (For more information, read my interview with Dr. Rao.) At that time Dr. Rao calculated the usage of transradial angioplasty in the U.S. at 1.32%.
Today’s report tabulates it at 6.9%: a five-fold increase!
Dr. Rao has been one of the main proponents of the transradial approach in the U.S., practicing it, teaching it, lecturing all over the country about it, and most recently co-directing a “Masters Course” in transradial at Duke. Continue reading →
October 15, 2012 · 7:59 pm
The TCT will be held in Miami Beach, October 22-26, 2012
The Transcatheter Cardiovascular Therapeutics conference (TCT) is the largest U.S. meeting devoted to interventional cardiology (angioplasty, stents, and related procedures) and it starts next week. Organizers are predicting a new attendance record of over 12,000 cardiologists and associated healthcare professionals, as well as members of the device, imaging and pharmaceutical industries, venture capitalists, and press. Speaking of which, yes…I will be there and Angioplasty.Org will be reporting on late-breaking trials, new directions and innovative devices.
The annual meeting is truly international: attendees will be traveling from 70 countries; in fact, this year more than two-thirds of the registrants hail from outside the United States. Continue reading →